DYNAVAX TECHNOLOGIES CORP

Nasdaq:DVAX

Pharmaceutical Preparations·EMERYVILLE, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	2/20/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/6/24	→
↓

Earnings Releases (8-K)

28 shown

Filed	Period
11/5/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/20/25	Q1 FY2025	→
1/13/25	Q4 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

52 shown

Filed	Type	Description
2/10/26	Delisting	Entry into a Material Definitive Agreement	→
12/29/25	Exec Change	Entry into a Material Definitive Agreement	→
10/16/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/21/25	Reg FD	Regulation FD Disclosure	→
6/17/25	Vote	Material Modification to Rights of Security Holders	→
5/13/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/10/26	S-8 POS	S-8 POS	→
2/10/26	S-8 POS	S-8 POS	→
2/10/26	S-8 POS	S-8 POS	→
2/10/26	S-8 POS	S-8 POS	→
2/10/26	S-8 POS	S-8 POS	→
2/10/26	S-8 POS	S-8 POS	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

15-12G

Feb 20, 2026

0001193125-26-06021915-12G

—

10.5 KB

EFFECT

Feb 13, 2026

9999999995-26-000567

—

1.7 KB

Feb 11, 2026

0001193125-26-0466754

Feb 10, 2026

9.5 KB

SCHEDULE 13G/A

Feb 11, 2026

0001172661-26-000628

—

11.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044768S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044764S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044762S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044758S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044753S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044749S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044744S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044738S-8 POS

—

43.0 KB

S-8 POS

Feb 10, 2026

0001193125-26-044734S-8 POS

—

43.0 KB

Feb 10, 2026

0001777938-26-000004

Feb 10, 2026

36.8 KB

S-8 POS

Feb 10, 2026

0001193125-26-044728S-8 POS

—

43.0 KB

Feb 10, 2026

0001475990-26-000002

Feb 10, 2026

30.4 KB

Feb 10, 2026

0002067729-26-000002

Feb 10, 2026

12.2 KB

Feb 10, 2026

0001781117-26-000002

Feb 10, 2026

30.4 KB

Feb 10, 2026

0002054163-26-000002

Feb 10, 2026

11.1 KB

Feb 10, 2026

0001356256-26-000002

Feb 10, 2026

19.2 KB

Feb 10, 2026

0001805339-26-000002

Feb 10, 2026

17.4 KB

Feb 10, 2026

0001073407-26-000002

Feb 10, 2026

23.5 KB

Feb 10, 2026

0001818951-26-000002

Feb 10, 2026

19.6 KB

Feb 10, 2026

0001225755-26-000002

Feb 10, 2026

11.0 KB

Feb 10, 2026

0001286710-26-000002

Feb 10, 2026

19.6 KB

25 filings shown

Filed	Form	Description
6/9/25	DEFA14A	DEFA14A	→
6/6/25	DEFA14A	DEFA14A	→
6/5/25	DEFA14A	DEFA14A	→
6/4/25	DEFA14A	DEFA14A	→
5/23/25	DEFA14A	DEFA14A	→
5/19/25	DEFA14A	DEFA14A	→
↓

DYNAVAX TECHNOLOGIES CORP

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/11/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
↓

Filed	Form	Description
2/20/26	15-12G	15-12G	→
2/13/26	EFFECT	EFFECT	→
2/11/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/10/26	POS AM	POS AM	→
2/10/26	25-NSE	25-NSE	→
2/10/26	SC 14D9/A	SC 14D9/A	→
↓